Delivery Order SPE2DB20D9127-SPE2DB25FPPN5

Award Date 1/6/25
Potential Completion Date 1/28/25
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,049.40 contract is for the delivery of 4565768340 - KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities and veterans' medical centers. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $7,031.04 contract is for the delivery of 4560094622 - KYLEENA 19.5 MG SYSTEMS, a contraceptive product, to support the medical supply needs of U.S. military health facilities worldwide. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $6,896.40 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the medical product "KYLEENA 19.5 MG SYSTEMS." This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. The IDC enables DLA to issue delivery orders for a comprehensive range of...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $2,873.50 and covers the delivery of 4565361226 KYLEENA 19.5 MG SYSTEMS. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which allows...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of KYLEENA 19.5 MG SYSTEMS, a type of pharmaceutical product, with an ultimate completion date of April 16, 2024, and a ceiling value of $15,048.00. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,009.65 contract is for the delivery of Kyleena 19.5 mg systems, a contraceptive product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,755.64 contract is for the delivery of 4558198525 KYLEENA 19.5 MG SYSTEMS, a contraceptive medication. The contract has an ultimate completion date of September 8, 2022 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a $499,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,448.20 contract is for the delivery of the KYLEENA 19.5 MG SYSTEMS medical device. The contract has a period of performance through July 23, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,859.15 delivery order is for the supply of 4564095562 - KYLEENA 19.5 MG SYSTEMS, a specialty pharmaceutical product. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $8,174.18, is for the delivery of 4566796532 KYLEENA 19.5 MG SYSTEMS, a specialized pharmaceutical product. The award is part of a larger single-award Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, valued at...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPPN5
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $6,196.90 contract is for the supply of 4566881194 KYLEENA 19.5 MG SYSTEMS, a medical product, to support the recurring medical supply needs of military healthcare facilities.

DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract is not associated with any set-aside designation, enabling DMS Pharmaceutical Group Inc. to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.

Generated 4/7/25, 9:46 AM